About TRANSCAN

Translational cancer research is key for addressing, understanding and preventing cancer, a worldwide health concern despite the continuous advancement of research and treatment approaches.

The ERA-NET TRANSCAN-3 is part of the Horizon 2020 Framework Programme (till Feb 2026) and is entitled: ERA-NET: Sustained collaboration of national and regional programmes in cancer research.

The ERA-NET TRANSCAN-3 has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research. The EU-funded TRANSCAN-3 project is bringing together 31 funding organisations from 20 countries and is supporting high-impact translational cancer research. Through cross-national joint calls for proposals and making the most of international and interregional cooperation, TRANSCAN-3 aims to provide influential contributions as well as a sustainable model of funding for ground-breaking translational cancer research in Europe and beyond.